🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 21% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

37 Gram(s) Serving Size
21 Servings
Other Combinations Product Type
21% Evidence Coverage

Supplement Facts — Evidence Check

Calories
160 Calorie(s)
Total Fat
5 Gram(s) (6% DV)
Total Carbohydrates
11 Gram(s) (4% DV)
Protein
17 Gram(s) (34% DV)
4 mcg (3% DV)
📊 Market median: 0.1mg (347 products) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.004mg
70 mg (13% DV)
✅ Within RDA (0.1× RDA of 550 mg) 📚 36 studies (Tier A: 1, B: 7)
RDA 550mg This product: 70mg UL 3500mg
Calcium
70 mg (5% DV)
Iron
4 mg (22% DV)
70 mg (17% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 70mg
Sodium
190 mg (8% DV)
Potassium
230 mg (5% DV)
1300 mg
📊 Market median: 500.0mg (143 products)
This product: 1300mg
Glycine
600 mg
850 mg
📊 Market median: 17.4mg (161 products)
Median 17.4mg This product: 850mg
1600 mg
📊 Market median: 17.4mg (161 products)
Median 17.4mg This product: 1600mg
300 mg
📊 Market median: 500.0mg (193 products) 📚 7 studies — no high-quality reviews
This product: 300mg
L-Valine
900 mg
600 mg
📊 Market median: 5.0mg (298 products) 📚 701 studies (Tier A: 5, B: 123)
This product: 600mg
Proprietary Blend
34.4 Gram(s)

Other Ingredients

Creatine L-Leucine Xanthan Gum L-Isoleucine L-Valine DL-Methionine Monk Fruit Extract Choline Bitartrate

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: Two heaping scoops in 10-12 ounces water, one to three servings per day, or as directed.

⚠️ Warnings & Precautions

Warning: This product contains naturally occurring Vitamin K1.

If you are taking blood-thinning medicines, are pregnant, nursing, or have been directed to eat a diet low in oxalates, please consult with your health care professional before taking this product.

Not intended for long-term use unless otherwise directed by your health care professional.

Keep out of reach of children.

🧪 Formulation Notes

Whole body detoxification

Vegan

GF (Gluten free)

Additional Information

Store in a cool, dry place once opened.

Vegan

Whole Food Supplements Since 1929

Product Details

UPC / SKU 8 12122 01688 9
DSLD Entry Date 2025-09-25
Product Type Other Combinations
Form Powder
DSLD ID 340373
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →